Magali Cordaillat-Simmons

Magali Cordaillat-Simmons earned her PhD in 2005 at Université Descartes - Paris, France, in Cardiovascular Pharmacology. She then worked as a Research Associate at the University of Virginia, USA, where she studied the influence of epigenetics on renin expression.

For 14 years she was Scientific & Regulatory Affairs Director at the Pharmabiotic Research Institute (PRI), located in France.The PRI is Europe’s first and only expert regulatory group dedicated to supporting its members in the development and market authorization of Microbiotic Medicinal Products (MMPs). As a non-profit, Pro-industry organization, the PRI is uniquely positioned to both be a trusted point of contact for the European regulatory authorities, as well as an agile and neutral partner for the Microbiome/Health industries. Dr. Cordaillat-Simmons supervised the Association’s analysis of the European Pharmaceutical Regulatory framework as well as the PRI’s regulatory intelligence strategy so that “Microbiotic Medicinal Products” become a therapeutic reality for European patients.

Today Magali Cordaillat-Simmons has Joined the University Clermont Auvergne as Junior Professor where she focuses her research on regulatory science aspects such as the impact of manufacturing processes on functionality of microbial strains and their effect on human health.